Marc Pierre Jean Dunoyer is Chief Financial Officer & Executive Director at AstraZeneca Plc and on the board of 5 other companies.

In the past he occupied the position of Global Head-Rare Diseases Unit at GlaxoSmithKline Plc and Chairman of GlaxoSmithKline KK (a subsidiary of GlaxoSmithKline Plc) and President-Asia Pacific at Hoechst Marion Roussel SA.

Mr. Dunoyer received an MBA from Hautes Etudes Commerciales and a graduate degree from University Paris-Sorbonne (Paris IV).